Menu

Wolfson Institute of Preventive Medicine

Search - ZOO
Search - K2
Search - Categories
Search - Contacts
Search - Content
Search - Newsfeeds
Search - Weblinks

Chrysi Stefanidou, BSc (Hons), MSc, PhD, CPsychol

Teaching Fellow

email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Tel: +44 (0)20 7882 2030

Profile

Chrysi is Teaching Fellow in Abnormal and Clinical Psychology at the Centre for Psychiatry.

She is a Chartered Psychologist and earned her MSc in Child and Adolescent Mental Health from the Institute of Psychiatry, Kings College London, and her PhD in Psychology (Developmental Neuroscience) from the University of Birmingham. Chrysi conducted her doctoral research in the neuro-developmental basis of social and language development in young children with autism spectrum disorders and toddlers at risk for autism by using Electroencephalography (EEG).

Her post-doctoral research with Prof. Chris Oliver and Dr. Jo Moss at the Cerebra Centre for Neuro-developmental Disorders, University of Birmingham, was funded by the Leverhulme Trust and focused on the study of social cognition and neural underpinnings of social development in individuals with autism and rare genetic syndromes, including Fragile X syndrome, Cornelia de Lange Syndrome and Rubinstein Taybi Syndrome. Chrysi has also been involved in other clinical research projects focusing on the effectiveness of psychological interventions for children with neuro-developmental disorders and autism, as well as in an NIHR-funded pilot study assessing the feasibility and impact of a brief motivational intervention on problem drug and alcohol use in adult mental health inpatient units.

Having trained and worked in several clinical, educational and research settings, Chrysi has over 15 years of experience working with individuals with neurodevelopmental disorders and mental health difficulties. She is also a certified trainer on the Autism Diagnostic Observation Schedule (ADOS-G) and has trained and supervised both academic research and clinical teams on the use and clinical interpretation of the ADOS-G.

Return to top